Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer.

Journal of thoracic disease

Tartarone A, Lerose R, Rodriquenz MG, Mambella G, Calderoni G, Bozza G, Aieta M.
PMID: 29184674
J Thorac Dis. 2017 Oct;9:S1359-S1363. doi: 10.21037/jtd.2017.07.80.

Circulating tumor cells (CTCs) are rare epithelial cells that can be found in the peripheral blood of cancer patients. A growing body of evidence indicates that CTCs may play a role in non-small cell lung cancer (NSCLC) for diagnosis,...

Cite
Tartarone A, Lerose R, Rodriquenz MG, et al. Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer. J Thorac Dis. 2017;9:S1359-S1363doi: 10.21037/jtd.2017.07.80.
Tartarone, A., Lerose, R., Rodriquenz, M. G., Mambella, G., Calderoni, G., Bozza, G., & Aieta, M. (2017). Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer. Journal of thoracic disease, 9S1359-S1363. https://doi.org/10.21037/jtd.2017.07.80
Tartarone, Alfredo, et al. "Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer." Journal of thoracic disease vol. 9 (2017): S1359-S1363. doi: https://doi.org/10.21037/jtd.2017.07.80
Tartarone A, Lerose R, Rodriquenz MG, Mambella G, Calderoni G, Bozza G, Aieta M. Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer. J Thorac Dis. 2017 Oct;9:S1359-S1363. doi: 10.21037/jtd.2017.07.80. PMID: 29184674; PMCID: PMC5676102.
Copy Download .nbib Format: NLM
Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis.

Artificial organs

Patrono D, Roggio D, Mazzeo AT, Catalano G, Mazza E, Rizza G, Gambella A, Rigo F, Leone N, Elia V, Dondossola D, Lonati C, Fanelli V, Romagnoli R.
PMID: 34516020
Artif Organs. 2022 Feb;46(2):281-295. doi: 10.1111/aor.14066. Epub 2021 Sep 21.

BACKGROUND: While growing evidence supports the use of hypothermic oxygenated machine perfusion (HOPE) in liver transplantation, its effects on liver metabolism are still incompletely understood.METHODS: To assess liver metabolism during HOPE using microdialysis (MD), we conducted an open-label, observational...

Cite
Patrono D, Roggio D, Mazzeo AT, et al. Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis. Artif Organs. 2021;46(2):281-295doi: 10.1111/aor.14066.
Patrono, D., Roggio, D., Mazzeo, A. T., Catalano, G., Mazza, E., Rizza, G., Gambella, A., Rigo, F., Leone, N., Elia, V., Dondossola, D., Lonati, C., Fanelli, V., & Romagnoli, R. (2022). Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis. Artificial organs, 46(2), 281-295. https://doi.org/10.1111/aor.14066
Patrono, Damiano, et al. "Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis." Artificial organs vol. 46,2 (2022): 281-295. doi: https://doi.org/10.1111/aor.14066
Patrono D, Roggio D, Mazzeo AT, Catalano G, Mazza E, Rizza G, Gambella A, Rigo F, Leone N, Elia V, Dondossola D, Lonati C, Fanelli V, Romagnoli R. Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis. Artif Organs. 2022 Feb;46(2):281-295. doi: 10.1111/aor.14066. Epub 2021 Sep 21. PMID: 34516020.
Copy Download .nbib Format: NLM
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing.

Clinical cancer research : an official journal of the American Association for Cancer Research

D'Agostino M, Zaccaria GM, Ziccheddu B, Rustad EH, Genuardi E, Capra A, Oliva S, Auclair D, Yesil J, Colucci P, Keats JJ, Gambella M, Bringhen S, Larocca A, Boccadoro M, Bolli N, Maura F, Gay F.
PMID: 32616499
Clin Cancer Res. 2020 Sep 15;26(18):4832-4841. doi: 10.1158/1078-0432.CCR-20-0951. Epub 2020 Jul 02.

PURPOSE: Duration of first remission is important for the survival of patients with multiple myeloma.EXPERIMENTAL DESIGN: From the CoMMpass study (NCT01454297), 926 patients with newly diagnosed multiple myeloma, characterized by next-generation sequencing, were analyzed to evaluate those who experienced...

Cite
D'Agostino M, Zaccaria GM, Ziccheddu B, et al. Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing. Clin Cancer Res. 2020;26(18):4832-4841doi: 10.1158/1078-0432.CCR-20-0951.
D'Agostino, M., Zaccaria, G. M., Ziccheddu, B., Rustad, E. H., Genuardi, E., Capra, A., Oliva, S., Auclair, D., Yesil, J., Colucci, P., Keats, J. J., Gambella, M., Bringhen, S., Larocca, A., Boccadoro, M., Bolli, N., Maura, F., & Gay, F. (2020). Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing. Clinical cancer research : an official journal of the American Association for Cancer Research, 26(18), 4832-4841. https://doi.org/10.1158/1078-0432.CCR-20-0951
D'Agostino, Mattia, et al. "Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26,18 (2020): 4832-4841. doi: https://doi.org/10.1158/1078-0432.CCR-20-0951
D'Agostino M, Zaccaria GM, Ziccheddu B, Rustad EH, Genuardi E, Capra A, Oliva S, Auclair D, Yesil J, Colucci P, Keats JJ, Gambella M, Bringhen S, Larocca A, Boccadoro M, Bolli N, Maura F, Gay F. Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing. Clin Cancer Res. 2020 Sep 15;26(18):4832-4841. doi: 10.1158/1078-0432.CCR-20-0951. Epub 2020 Jul 02. PMID: 32616499.
Copy Download .nbib Format: NLM
Spatial lay-out of various smooth muscles.

Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi

Gabella G.
PMID: 34545005
J Smooth Muscle Res. 2021;57:19-34. doi: 10.1540/jsmr.57.19.

The characteristic mechanical activities of the smooth muscles found in all organs of the body are highly variable and depend mainly on the spatial arrangement of the muscle cells and the stroma: mass, orientation, relationships, links, constraints, which are...

Cite
Gabella G. Spatial lay-out of various smooth muscles. J Smooth Muscle Res. 2021;57:19-34doi: 10.1540/jsmr.57.19.
Gabella, G. (2021). Spatial lay-out of various smooth muscles. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 5719-34. https://doi.org/10.1540/jsmr.57.19
Gabella, Giorgio. "Spatial lay-out of various smooth muscles." Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi vol. 57 (2021): 19-34. doi: https://doi.org/10.1540/jsmr.57.19
Gabella G. Spatial lay-out of various smooth muscles. J Smooth Muscle Res. 2021;57:19-34. doi: 10.1540/jsmr.57.19. PMID: 34545005; PMCID: PMC8443803.
Copy Download .nbib Format: NLM
Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis.

Artificial organs

Patrono D, Roggio D, Mazzeo AT, Catalano G, Mazza E, Rizza G, Gambella A, Rigo F, Leone N, Elia V, Dondossola D, Lonati C, Fanelli V, Romagnoli R.
PMID: 34516020
Artif Organs. 2021 Sep 13; doi: 10.1111/aor.14066. Epub 2021 Sep 13.

BACKGROUND: While growing evidence supports the use of hypothermic oxygenated machine perfusion (HOPE) in liver transplantation, its effects on liver metabolism are still incompletely understood.METHODS: To assess liver metabolism during HOPE using microdialysis (MD), we conducted an open-label, observational...

Cite
Patrono D, Roggio D, Mazzeo AT, et al. Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis. Artif Organs. 2021;doi: 10.1111/aor.14066.
Patrono, D., Roggio, D., Mazzeo, A. T., Catalano, G., Mazza, E., Rizza, G., Gambella, A., Rigo, F., Leone, N., Elia, V., Dondossola, D., Lonati, C., Fanelli, V., & Romagnoli, R. (2021). Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis. Artificial organs, . https://doi.org/10.1111/aor.14066
Patrono, Damiano, et al. "Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis." Artificial organs vol. (2021). doi: https://doi.org/10.1111/aor.14066
Patrono D, Roggio D, Mazzeo AT, Catalano G, Mazza E, Rizza G, Gambella A, Rigo F, Leone N, Elia V, Dondossola D, Lonati C, Fanelli V, Romagnoli R. Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis. Artif Organs. 2021 Sep 13; doi: 10.1111/aor.14066. Epub 2021 Sep 13. PMID: 34516020.
Copy Download .nbib Format: NLM
Caveolin-1 in Kidney Chronic Antibody-Mediated Rejection: An Integrated Immunohistochemical and Transcriptomic Analysis Based on the Banff Human Organ Transplant (B-HOT) Gene Panel.

Biomedicines

Gambella A, Barreca A, Osella-Abate S, Bottasso E, Giarin MM, Papotti M, Biancone L, Metovic J, Collemi G, Cassoni P, Bertero L.
PMID: 34680435
Biomedicines. 2021 Sep 26;9(10). doi: 10.3390/biomedicines9101318.

Caveolin-1 overexpression has previously been reported as a marker of endothelial injury in kidney chronic antibody-mediated rejection (c-ABMR), but conclusive evidence supporting its use for daily diagnostic practice is missing. This study aims to evaluate if Caveolin-1 can be...

Cite
Gambella A, Barreca A, Osella-Abate S, et al. Caveolin-1 in Kidney Chronic Antibody-Mediated Rejection: An Integrated Immunohistochemical and Transcriptomic Analysis Based on the Banff Human Organ Transplant (B-HOT) Gene Panel. Biomedicines. 2021;9(10)doi: 10.3390/biomedicines9101318.
Gambella, A., Barreca, A., Osella-Abate, S., Bottasso, E., Giarin, M. M., Papotti, M., Biancone, L., Metovic, J., Collemi, G., Cassoni, P., & Bertero, L. (2021). Caveolin-1 in Kidney Chronic Antibody-Mediated Rejection: An Integrated Immunohistochemical and Transcriptomic Analysis Based on the Banff Human Organ Transplant (B-HOT) Gene Panel. Biomedicines, 9(10), . https://doi.org/10.3390/biomedicines9101318
Gambella, Alessandro, et al. "Caveolin-1 in Kidney Chronic Antibody-Mediated Rejection: An Integrated Immunohistochemical and Transcriptomic Analysis Based on the Banff Human Organ Transplant (B-HOT) Gene Panel." Biomedicines vol. 9,10 (2021). doi: https://doi.org/10.3390/biomedicines9101318
Gambella A, Barreca A, Osella-Abate S, Bottasso E, Giarin MM, Papotti M, Biancone L, Metovic J, Collemi G, Cassoni P, Bertero L. Caveolin-1 in Kidney Chronic Antibody-Mediated Rejection: An Integrated Immunohistochemical and Transcriptomic Analysis Based on the Banff Human Organ Transplant (B-HOT) Gene Panel. Biomedicines. 2021 Sep 26;9(10). doi: 10.3390/biomedicines9101318. PMID: 34680435; PMCID: PMC8533527.
Copy Download .nbib Format: NLM
Advances in Unmanned Aerial System Remote Sensing for Precision Viticulture.

Sensors (Basel, Switzerland)

Sassu A, Gambella F, Ghiani L, Mercenaro L, Caria M, Pazzona AL.
PMID: 33535445
Sensors (Basel). 2021 Feb 01;21(3). doi: 10.3390/s21030956.

New technologies for management, monitoring, and control of spatio-temporal crop variability in precision viticulture scenarios are numerous. Remote sensing relies on sensors able to provide useful data for the improvement of management efficiency and the optimization of inputs. unmanned...

Cite
Sassu A, Gambella F, Ghiani L, et al. Advances in Unmanned Aerial System Remote Sensing for Precision Viticulture. Sensors (Basel). 2021;21(3)doi: 10.3390/s21030956.
Sassu, A., Gambella, F., Ghiani, L., Mercenaro, L., Caria, M., & Pazzona, A. L. (2021). Advances in Unmanned Aerial System Remote Sensing for Precision Viticulture. Sensors (Basel, Switzerland), 21(3), . https://doi.org/10.3390/s21030956
Sassu, Alberto, et al. "Advances in Unmanned Aerial System Remote Sensing for Precision Viticulture." Sensors (Basel, Switzerland) vol. 21,3 (2021). doi: https://doi.org/10.3390/s21030956
Sassu A, Gambella F, Ghiani L, Mercenaro L, Caria M, Pazzona AL. Advances in Unmanned Aerial System Remote Sensing for Precision Viticulture. Sensors (Basel). 2021 Feb 01;21(3). doi: 10.3390/s21030956. PMID: 33535445; PMCID: PMC7867093.
Copy Download .nbib Format: NLM
An Open-Source ROS-Gazebo Toolbox for Simulating Robots With Compliant Actuators.

Frontiers in robotics and AI

Mengacci R, Zambella G, Grioli G, Caporale D, Catalano MG, Bicchi A.
PMID: 34458326
Front Robot AI. 2021 Aug 11;8:713083. doi: 10.3389/frobt.2021.713083. eCollection 2021.

To enable the design of planning and control strategies in simulated environments before their direct application to the real robot, exploiting the

Cite
Mengacci R, Zambella G, Grioli G, et al. An Open-Source ROS-Gazebo Toolbox for Simulating Robots With Compliant Actuators. Front Robot AI. 2021;8:713083doi: 10.3389/frobt.2021.713083.
Mengacci, R., Zambella, G., Grioli, G., Caporale, D., Catalano, M. G., & Bicchi, A. (2021). An Open-Source ROS-Gazebo Toolbox for Simulating Robots With Compliant Actuators. Frontiers in robotics and AI, 8713083. https://doi.org/10.3389/frobt.2021.713083
Mengacci, Riccardo, et al. "An Open-Source ROS-Gazebo Toolbox for Simulating Robots With Compliant Actuators." Frontiers in robotics and AI vol. 8 (2021): 713083. doi: https://doi.org/10.3389/frobt.2021.713083
Mengacci R, Zambella G, Grioli G, Caporale D, Catalano MG, Bicchi A. An Open-Source ROS-Gazebo Toolbox for Simulating Robots With Compliant Actuators. Front Robot AI. 2021 Aug 11;8:713083. doi: 10.3389/frobt.2021.713083. eCollection 2021. PMID: 34458326; PMCID: PMC8385715.
Copy Download .nbib Format: NLM
Integrating the RFID identification system for Charolaise breeding bulls with 3D imaging for virtual archive creation.

PeerJ. Computer science

Cappai MG, Gambella F, Piccirilli D, Rubiu NG, Dimauro C, Pazzona AL, Pinna W.
PMID: 33816832
PeerJ Comput Sci. 2019 Mar 04;5:e179. doi: 10.7717/peerj-cs.179. eCollection 2019.

The individual electronic identification (EID) of cattle based on RFID technology (134.2 kHz ISO standard 11784) will definitely enter into force in European countries as an official means of animal identification from July 2019. Integrating EID with 3D digital...

Cite
Cappai MG, Gambella F, Piccirilli D, et al. Integrating the RFID identification system for Charolaise breeding bulls with 3D imaging for virtual archive creation. PeerJ Comput Sci. 2019;5:e179doi: 10.7717/peerj-cs.179.
Cappai, M. G., Gambella, F., Piccirilli, D., Rubiu, N. G., Dimauro, C., Pazzona, A. L., & Pinna, W. (2019). Integrating the RFID identification system for Charolaise breeding bulls with 3D imaging for virtual archive creation. PeerJ. Computer science, 5e179. https://doi.org/10.7717/peerj-cs.179
Cappai, Maria Grazia, et al. "Integrating the RFID identification system for Charolaise breeding bulls with 3D imaging for virtual archive creation." PeerJ. Computer science vol. 5 (2019): e179. doi: https://doi.org/10.7717/peerj-cs.179
Cappai MG, Gambella F, Piccirilli D, Rubiu NG, Dimauro C, Pazzona AL, Pinna W. Integrating the RFID identification system for Charolaise breeding bulls with 3D imaging for virtual archive creation. PeerJ Comput Sci. 2019 Mar 04;5:e179. doi: 10.7717/peerj-cs.179. eCollection 2019. PMID: 33816832; PMCID: PMC7924494.
Copy Download .nbib Format: NLM
HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Sorbini M, Togliatto GM, Simonato E, Boffini M, Cappuccio M, Gambella A, Arruga F, Mora N, Marro M, Caorsi C, Mansouri M, Magistroni P, Delsedime L, Papotti MG, Amoroso A, Rinaldi M, Vaisitti T, Deaglio S.
PMID: 34134912
J Heart Lung Transplant. 2021 Aug;40(8):794-804. doi: 10.1016/j.healun.2021.05.001. Epub 2021 May 14.

BACKGROUND: Donor-derived cell-free DNA (dd-cfDNA) is considered a reliable marker of organ damage with potential applications in the follow-up of transplant recipients.METHODS: In this work we present an assay based on the donor-recipient HLA-mismatch (human leukocyte antigen) at the...

Cite
Sorbini M, Togliatto GM, Simonato E, et al. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study. J Heart Lung Transplant. 2021;40(8):794-804doi: 10.1016/j.healun.2021.05.001.
Sorbini, M., Togliatto, G. M., Simonato, E., Boffini, M., Cappuccio, M., Gambella, A., Arruga, F., Mora, N., Marro, M., Caorsi, C., Mansouri, M., Magistroni, P., Delsedime, L., Papotti, M. G., Amoroso, A., Rinaldi, M., Vaisitti, T., & Deaglio, S. (2021). HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 40(8), 794-804. https://doi.org/10.1016/j.healun.2021.05.001
Sorbini, Monica, et al. "HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study." The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. 40,8 (2021): 794-804. doi: https://doi.org/10.1016/j.healun.2021.05.001
Sorbini M, Togliatto GM, Simonato E, Boffini M, Cappuccio M, Gambella A, Arruga F, Mora N, Marro M, Caorsi C, Mansouri M, Magistroni P, Delsedime L, Papotti MG, Amoroso A, Rinaldi M, Vaisitti T, Deaglio S. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study. J Heart Lung Transplant. 2021 Aug;40(8):794-804. doi: 10.1016/j.healun.2021.05.001. Epub 2021 May 14. PMID: 34134912.
Copy Download .nbib Format: NLM
Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis.

Cancers

Borella F, Bertero L, Morrone A, Gambella A, Bovetti M, Cosma S, Carosso A, Katsaros D, Gemmiti S, Preti M, Valabrega G, Scotto G, Cassoni P, Benedetto C.
PMID: 32759682
Cancers (Basel). 2020 Aug 04;12(8). doi: 10.3390/cancers12082156.

With this review, we provide the state of the art concerning brain metastases (BMs) from ovarian cancer (OC), a rare condition. Clinical, pathological, and molecular features, treatment options, and future perspectives are comprehensively discussed. Overall, a diagnosis of high-grade...

Cite
Borella F, Bertero L, Morrone A, et al. Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis. Cancers (Basel). 2020;12(8)doi: 10.3390/cancers12082156.
Borella, F., Bertero, L., Morrone, A., Gambella, A., Bovetti, M., Cosma, S., Carosso, A., Katsaros, D., Gemmiti, S., Preti, M., Valabrega, G., Scotto, G., Cassoni, P., & Benedetto, C. (2020). Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis. Cancers, 12(8), . https://doi.org/10.3390/cancers12082156
Borella, Fulvio, et al. "Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis." Cancers vol. 12,8 (2020). doi: https://doi.org/10.3390/cancers12082156
Borella F, Bertero L, Morrone A, Gambella A, Bovetti M, Cosma S, Carosso A, Katsaros D, Gemmiti S, Preti M, Valabrega G, Scotto G, Cassoni P, Benedetto C. Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis. Cancers (Basel). 2020 Aug 04;12(8). doi: 10.3390/cancers12082156. PMID: 32759682; PMCID: PMC7464214.
Copy Download .nbib Format: NLM
Caveolin-1 expression predicts favourable outcome and correlates with .

Journal of clinical pathology

Bertero L, Gambella A, Barreca A, Osella-Abate S, Chiusa L, Francia di Celle P, Lista P, Papotti M, Cassoni P.
PMID: 34155091
J Clin Pathol. 2021 Jun 21; doi: 10.1136/jclinpath-2021-207595. Epub 2021 Jun 21.

AIMS: Novel prognostic markers are warranted for gastrointestinal stromal tumours. Caveolin-1 is a multifunctional protein that proved to be associated with outcome in multiple tumour types. Aim of this study was to investigate Caveolin-1 expression and prognostic efficacy in...

Cite
Bertero L, Gambella A, Barreca A, et al. Caveolin-1 expression predicts favourable outcome and correlates with . J Clin Pathol. 2021;doi: 10.1136/jclinpath-2021-207595.
Bertero, L., Gambella, A., Barreca, A., Osella-Abate, S., Chiusa, L., Francia di Celle, P., Lista, P., Papotti, M., & Cassoni, P. (2021). Caveolin-1 expression predicts favourable outcome and correlates with . Journal of clinical pathology, . https://doi.org/10.1136/jclinpath-2021-207595
Bertero, Luca, et al. "Caveolin-1 expression predicts favourable outcome and correlates with ." Journal of clinical pathology vol. (2021). doi: https://doi.org/10.1136/jclinpath-2021-207595
Bertero L, Gambella A, Barreca A, Osella-Abate S, Chiusa L, Francia di Celle P, Lista P, Papotti M, Cassoni P. Caveolin-1 expression predicts favourable outcome and correlates with . J Clin Pathol. 2021 Jun 21; doi: 10.1136/jclinpath-2021-207595. Epub 2021 Jun 21. PMID: 34155091.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries